Expression and significance of c-fos in resistant cell line TU177/VCR of larynx squamous cell carcinoma

Guodong Li,Xiaoling Hu,Jianfeng Xing,Ruyi Shi,Xin Li,Jianfeng Li,Tongli Li
DOI: https://doi.org/10.3760/cma.j.issn.1673-0860.2018.04.008
2018-01-01
Abstract:Objective To explore the effect of c-los on multidrug resistance of laryngeal cancer TU177 cells.Method Increasing drug concentration gradient is adopted to establish the stability of the laryngeal cancer drug resistance in cell line;RT-PCR and Western blot were used to detect difference of the c-fos between TU177 and TU177/VCR cells;plasmids with human c-fos knockdown or over expression were transfected into TU177/VCR and TU177 cells respectively,and the effects of different treatment on cell proliferation were investigated with MTT.Results The drug resistance of TU177/VCR cells was 26.25-fold in vincristine (VCR),7.33-fold in Paclitaxel (TAX),2.41 in cisplatin (DDP),and 5.50 in 5-fluorouracil (5-FU),comparing with TU177 (P< 0.05).The TU177/VCR cells had significantly higher c-fos expression compared to TU177 cells(P <0.05).The results showed that the IC50 values of 5-FU for the NC group and c-fos shRNA group were (306.2 ± 6.3) μmol/L and (81.3 ± 3.9) μmol/L,respectively,which was decreased by 73% in the c-fos shRNA group compared to that in the NC group (P <0.05).Similarly,the results showed that the IC50 values for 5-FU were (55.3 ± 9.4) μmol/L in NC group and (288.1 ± 7.3) μmol/L in c-fos WT group,which was increased 5.21-fold in c-fos WT cells.Conclusion C-fos plays important role in multidrug resistance of larynx cancer cell TU177/VCR,and might become a new molecular target for laryngeal cancer treatment.
What problem does this paper attempt to address?